The 2025 update also highlights CGM consideration for adults with type 2 diabetes on glucose-lowering agents beyond insulin when clinically appropriate
Other Articles Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, Reuben A, Chow CW, McGranahan N, Chen R, Hu J, Godoy MC, Tabata K, Kuroda K, Shi L, Li J, Behrens C, Parra ER, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Kadara H, Scheet P, Roarty E, Ostrin EJ, Wang X, Carter BW, Antonoff MB, Zhang J, Vaporciyan AA, Pass H, Swisher SG , Heymach JV, Lee JJ, Wistuba II, Hong WK, Futreal PA, Su D, Zhang J Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Supports rapid recovery and boosted energy levels
Sperm morphology was not affected
36 studies were included (35 preclinical [rodents] studies, 1 clinical [humans] study)